SCHEMBL29976154

SCHEMBL29976154

O=C(O)c1cncc(OC(=O)N2CCC(Oc3ccc(OCc4cccc(F)c4)cc3)CC2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.62
NR4A2 P43354 2/20 0.52
ALKBH1 Q13686 1/20 0.45
MAOB P27338 6/20 0.44
MAOA P21397 3/20 0.44
MMP13 P45452 1/20 0.44
MMP14 P50281 1/20 0.44
PARP10 Q53GL7 1/20 0.44
PPARA Q07869 1/20 0.44
F10 P00742 1/20 0.44
GRIN2B Q13224 1/20 0.43
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
GFER P55789 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1532715 1.00 FAAH (0.62) FAAHNR4A2ALKBH1MAOBMAOA
SCHEMBL16333042 0.92 FAAH (0.61) FAAHMAOBMAOAMMP13MMP14
SCHEMBL1532829 0.91 FAAH (0.54) FAAHNR4A2MEN1HTTGFER
SCHEMBL1532838 0.90 FAAH (0.57) FAAHNR4A2MAOBMAOAMMP13
SCHEMBL1532790 0.87 FAAH (0.68) FAAHNR4A2MAOBMAOAMMP13
SCHEMBL1532894 0.86 FAAH (0.58) FAAHNR4A2MAOBMAOAMMP13
SCHEMBL1532895 0.86 FAAH (0.58) FAAHNR4A2MAOBMAOAMMP13
SCHEMBL12736284 0.86 FAAH (0.62) FAAHNR4A2ALKBH1MAOBMAOA
Oxalic Acid SCHEMBL1532922 0.85 FAAH (0.57) FAAHNR4A2MAOBMAOAMMP13
SCHEMBL2193693 0.85 FAAH (0.58) FAAHNR4A2ALKBH1MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583857-A1 METHODS FOR THE TREATMENT OF DEPRESSION Autobahn Therapeutics, Inc. (US) 2025-07-16 EP disclosed
WO-2024054996-A1 METHODS FOR THE TREATMENT OF DEPRESSION AUTOBAHN THERAPEUTICS, INC. (US) 2024-03-14 WO disclosed
EP-4333844-A1 FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF THYROMIMETICS AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS Autobahn Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2022236133-A1 FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF THYROMIMETICS AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS AUTOBAHN THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
WO-2022236118-A1 FATTY ACID AMIDE HYDROLASE (FAAH) CLEAVABLE PRODRUGS OF BRAIN TARGETING ACTIVES AND COMBINATION WITH PERIPHERALLY RESTRICTED FAAH INHIBITORS AUTOBAHN THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed